A carregar...
MDR1和CYP3A5基因多态性对伊马替尼治疗慢性骨髓性白血病预后的影响
OBJECTIVE: To study the effect of MDR1 and CYP3A5 gene polymorphisms on the outcomes of imatinib treatment in patients with chronic myeloid leukemia (CML). METHODS: A total of 100 patients with CML treated with imatinib were enrolled in this study, including 50 patients with cytogenetic relapse (stu...
Na minha lista:
| Publicado no: | Nan Fang Yi Ke Da Xue Xue Bao |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
南方医科大学学报编辑部
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6765618/ https://ncbi.nlm.nih.gov/pubmed/33177018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3969/j.issn.1673-4254.2018.01.06 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|